Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids

Area of Science:

• Neurochemistry
• Lipidomics
• Immunology

Background:

• Multiple Sclerosis (MS) is a demyelinating disease affecting the central nervous system (CNS).
• The origin of lipids within cerebrospinal fluid (CSF) in MS is not fully understood.
• Understanding CSF lipid profiles may offer insights into MS pathogenesis.

Purpose of the Study:

• To analyze and compare the lipid and fatty acid composition of CSF, serum, and lymphocytes in healthy controls and patients with acute and chronic MS.
• To determine the primary source of CSF lipids in the context of MS.
• To investigate alterations in CSF lipid profiles during different stages of MS.

Main Methods:

• Lipid fractions were isolated from CSF, serum, and lymphocytes using thin-layer chromatography (TLC).
• The fatty acid composition of individual lipid fractions was determined.
• Lipid profiles were compared between control subjects and MS patients (acute and chronic).

Main Results:

• Normal CSF lipid composition closely resembles that of lymphocytes, suggesting lymphocytes as the main source.
• In acute MS with pleocytosis, CSF sphingomyelin levels increase, likely from disintegrated lymphocytes.
• Elevated linoleic acid in CSF during acute MS suggests potential blood-brain barrier dysfunction.

Conclusions:

• CSF lipids are predominantly derived from lymphocytes, with a negligible contribution from CNS white matter.
• Changes in CSF lipid composition during acute MS reflect lymphocyte involvement and compromised blood-brain barrier integrity.
• Lipid analysis of CSF provides valuable information on the interplay between lymphocytes and the CNS in MS.